Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2023 Filed Feb 24, 2023 17:11 UTC |
Hudson Frederick M.Director
|
Disposition to issuerRestricted Stock Units · Derivative | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025376 · tm237737-2_4seq1.xml · derivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,882 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:11 UTC |
Hudson Frederick M.Director
|
GrantCommon Stock | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025376 · tm237737-2_4seq1.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,867 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:16 UTC |
SIEBERT JOHN MDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025383 · tm237737-5_4seq1.xml · derivative · entry 2 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,882 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:16 UTC |
SIEBERT JOHN MDirector
|
GrantCommon Stock | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025383 · tm237737-5_4seq1.xml · nonDerivative · entry 1 SIEBERT JOHN M · CIK 0001190558 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,057 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:03 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025371 · tm237737-9_4seq1.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:03 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025371 · tm237737-9_4seq1.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341 F1 · balance_after: Includes an aggregate of 841 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:14 UTC |
GEMAYEL GEORGESDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025380 · tm237737-4_4seq1.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,882 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:14 UTC |
GEMAYEL GEORGESDirector
|
GrantCommon Stock | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025380 · tm237737-4_4seq1.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,315 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:12 UTC |
Barlow CarroleeDirector
|
Disposition to issuerRestricted Stock Units · Derivative | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025377 · tm237737-3_4seq1.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,882 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. F2 · derivative.expiration_date: These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:12 UTC |
Barlow CarroleeDirector
|
GrantCommon Stock | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025377 · tm237737-3_4seq1.xml · nonDerivative · entry 1 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,315 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:06 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025373 · tm237737-10_4seq1.xml · derivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:06 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025373 · tm237737-10_4seq1.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,247 F1 · balance_after: Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:02 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Disposition to issuerRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025370 · tm237737-8_4seq1.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:02 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025370 · tm237737-8_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,323 F1 · balance_after: Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Mottola FrankSr VP, Quality, GMP Oper. & IT
|
Disposition to issuerRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044665 · tm2312277-3_4aseq.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · Sr VP, Quality, GMP Oper. & IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Mottola FrankSr VP, Quality, GMP Oper. & IT
|
Tax withholdingCommon Stock | 289 | $38.57 | $11,146.73 |
DisclosureSEC source: 0001104659-23-044665 · tm2312277-3_4aseq.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · Sr VP, Quality, GMP Oper. & IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,228 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Mottola FrankSr VP, Quality, GMP Oper. & IT
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044665 · tm2312277-3_4aseq.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · Sr VP, Quality, GMP Oper. & IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,517 F1 · balance_after: Includes an aggregate of 576 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:01 UTC Amendment |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044666 · tm2312277-4_4aseq1.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:01 UTC Amendment |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 193 | $38.57 | $7,444.01 |
DisclosureSEC source: 0001104659-23-044666 · tm2312277-4_4aseq1.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,148 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:01 UTC Amendment |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044666 · tm2312277-4_4aseq1.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,341 F1 · balance_after: Includes an aggregate of 841 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Disposition to issuerRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044664 · tm2312277-2_4aseq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Tax withholdingCommon Stock | 289 | $38.57 | $11,146.73 |
DisclosureSEC source: 0001104659-23-044664 · tm2312277-2_4aseq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,034 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2023 Filed Apr 12, 2023 21:00 UTC Amendment |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-044664 · tm2312277-2_4aseq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,323 F1 · balance_after: Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:01 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023832 · tm237193-2_4seq1.xml · derivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2031-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:01 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023832 · tm237193-2_4seq1.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:35 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionPerformance Share Unit · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023877 · tm237193-1_4seq1.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2031-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:35 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Tax withholdingCommon Stock | 753 | $38.74 | $29,171.22 |
DisclosureSEC source: 0001104659-23-023877 · tm237193-1_4seq1.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,191 F1 · price: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:35 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023877 · tm237193-1_4seq1.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:02 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantPerformance Share Unit · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023836 · tm237193-5_4seq1.xml · derivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2023-04-01 F1 · derivative.exercise_date: On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:38 UTC |
Khattar Jack A.Director · President, CEO
|
GrantPerformance Share Unit · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023878 · tm237193-4_4seq1.xml · derivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-04-01 F1 · derivative.exercise_date: On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:01 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionPerformance Share Unit · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023834 · tm237193-3_4seq1.xml · derivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2031-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 30, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 22:01 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-023834 · tm237193-3_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-022863 · tm237056-1_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the KBT Trust Disclosed balance after: 1,038,950 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 8,750 shares were transferred from the KBT Trust to the Reporting Person on February 15, 2023 without consideration and are now owned directly. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-022863 · tm237056-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 813,022 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 8,750 shares were transferred from the KBT Trust to the Reporting Person on February 15, 2023 without consideration and are now owned directly. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 330 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · derivative · entry 7 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,037 Underlying: Common Stock · 330 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F4 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
SaleCommon Stock | 200 | $42.02 | $8,404.00 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · nonDerivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,272 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.01 to $42.03, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 330 | $9.56 | $3,154.80 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · nonDerivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,515 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · derivative · entry 6 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,367 Underlying: Common Stock · 22,515 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F4 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
SaleCommon Stock | 13,532 | $42.06 | $569,088.26 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,142 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.09, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 22,515 | $9.56 | $215,243.40 |
DisclosureSEC source: 0001104659-23-011255 · tm235112-3_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 817,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 498 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-010575 · tm235112-2_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,882 Underlying: Common Stock · 498 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F3 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
SaleCommon Stock | 300 | $42.01 | $12,602.01 |
DisclosureSEC source: 0001104659-23-010575 · tm235112-2_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795,159 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.02, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 498 | $9.56 | $4,760.88 |
DisclosureSEC source: 0001104659-23-010575 · tm235112-2_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,620 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-009959 · tm235112-1_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,380 Underlying: Common Stock · 1,620 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F3 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
SaleCommon Stock | 976 | $42.01 | $41,002.35 |
DisclosureSEC source: 0001104659-23-009959 · tm235112-1_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,961 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.07, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 1,620 | $9.56 | $15,487.20 |
DisclosureSEC source: 0001104659-23-009959 · tm235112-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 795,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,080 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-005449 · tm233672-6_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 8,080 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F3 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
SaleCommon Stock | 4,936 | $40.40 | $199,394.16 |
DisclosureSEC source: 0001104659-23-005449 · tm233672-6_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,317 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.68, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 8,080 | $9.56 | $77,244.80 |
DisclosureSEC source: 0001104659-23-005449 · tm233672-6_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,920 | $0.00 Strike: $9.56 | $0.00 |
DisclosureSEC source: 0001104659-23-005057 · tm233672-5_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,080 Underlying: Common Stock · 41,920 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022. F3 · derivative.exercise_date: The options vested in four equal annual installments beginning on January 23, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.